Home > Insider Trading > Filing (0001770252-21-000011)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899923	Myriad Genetics Inc	MYGN	In Vitro & In Vivo Diagnostic Substances (2835)	870494517

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1770252	Nicole Lambert	320 Wakara Way Salt Lake City UT 84108	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-09-25	1,311	$33.31	191,610	No	4	F	Direct
Common Stock	Disposition	2021-09-26	3,426	$33.31	188,184	No	4	F	Direct
Common Stock	Disposition	2021-09-27	10,112	$33.10	178,072	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct

Footnotes

Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021.
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.43 to $33.62, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.